Report Overview:
The Global Short Bowel Syndrome Market achieved a valuation of $1.18 Billion in 2022 and is anticipated to exceed $4.44 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 18% during the forecast period from 2024 to 2032.
Key Market Players:
TAKEDA Inc (Japan), Nutrinia (Netherlands), OxThera (Sweden), VectivBio AG (Switzerland), Ardelyx (US)
Report Overview:
The Global Naloxone Spray Market achieved a valuation of $380 Million in 2022 and is anticipated to exceed $1.4 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 19.9% during the forecast period from 2024 to 2032.
Key Market Players:
Report Overview:
The Global Biosimilars Market achieved a valuation of $35.14 Billion in 2022 and is anticipated to exceed $216.32 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 25.5% during the forecast period from 2024 to 2032.
Key Market Players:
F. Hoffmann-La Roche Ltd. (US), Sandoz International GmbH (Switzerland), Dr. Reddy’s Laboratories Ltd. (India), Teva Pharmaceutical Industries Ltd. (Israel), Pfizer Inc. (US), Samsung Bioepis (South Korea), Biocon (India), and Mylan N.V (US).
Report Overview:
The Global Dystrophin Market achieved a valuation of $1.46 Billion in 2022 and is anticipated to exceed $29.53 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 45.6% during the forecast period from 2024 to 2032.
Key Market Players:
PTC Therapeutics, Sarepta Therapeutics, BioMarin Pharmaceutical Inc, Wave Life Sciences, Bristol-Myers Squibb and Catabasis Pharmaceuticals among others.
Report Overview:
The Global Peptide Cancer Vaccine Market achieved a valuation of $4.44 Billion in 2022 and is anticipated to exceed $10.31 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 11.1% during the forecast period from 2024 to 2032.
Key Market Players:
Report Overview:
The Global Viral Vector and Plasmid DNA Manufacturing Market achieved a valuation of $697.16 Million in 2022 and is anticipated to exceed $2285.58 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 16% during the forecast period from 2024 to 2032.
Key Market Players:
Fujifilm Diosynth Biotechnologies, Fujifilm Diosynth Biotechnologies (US), SIRION Biotech (Germany), Thermo Fisher Scientific (US), Merck KGaA Inc. (US), Cognate BioServices Inc. (Cobra Biologics) (US)
Report Overview:
The Global Organic Fruits And Vegetables Market achieved a valuation of $42.12 Billion in 2022 and is anticipated to exceed $77.95 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 8% during the forecast period from 2024 to 2032.
Key Market Players:
DMH Ingredients, CSC Brands LP (Campbell Soup Company), H.J. Heinz Company, Juices International Pty. Ltd., General Mills, Inc., Organic Valley Family of Farms, Activz, Z Natural Foods, LLC., Green Organic Vegetable Inc., The Whitewave Foods Company, and Iceland Foods Ltd.
Report Overview:
The Global Organic Rice Protein Market achieved a valuation of $112.10 Million in 2022 and is anticipated to exceed $421.37 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 18% during the forecast period from 2024 to 2032.
Key Market Players:
Report Overview:
The Global Genotyping Assay Market achieved a valuation of $14.36 Billion in 2022 and is anticipated to exceed $60.52 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 19.7% during the forecast period from 2024 to 2032.
Key Market Players:
Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Bioline, Qiagen, Danaher, F. Hoffmann-La Roche Ltd., General Electric, Sequenom, Fluidigm, Biogeniq Inc., Envigo, Helix, LGC Biosearch Technologies,
Report Overview:
The Global Sepsis Therapeutics Market achieved a valuation of $3.21 Billion in 2022 and is anticipated to exceed $5.52 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 7% during the forecast period from 2024 to 2032.
Key Market Players:
F. Hoffmann-La Roche Ltd, Pfizer Inc., GlaxoSmithKline Inc., Mylan NV, and Allergan Inc.
